Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
May 08 2023 - 9:15AM
Business Wire
Cue now offers over-the-counter and
prescription medications for sexual health, birth control, hair
loss, and more
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology
company, today announced an expansion of its Cue Integrated Care
Platform to include a new pharmacy offering with over-the-counter
and prescription medication options for a growing number of common
health and wellness needs. These include sexual health - such as
erectile dysfunction and herpes - as well as birth control, hair
loss, and more.
Building on last month’s launch of its new collection of
consumer-friendly, at-home diagnostic test kits, as well as
existing treatment options that Cue offers for infectious diseases
including COVID-19, influenza, and urinary tract infections, the
all-new pharmacy offering now provides individuals with a
convenient and private way to manage a growing number of common
health and wellness concerns.
“Many of the conditions for which we now offer care choices and
medication often go ignored or unaddressed due to a gap in
awareness or a lack of discreet access, which can lead to adverse
health effects,” said Dr. David Tsay, Chief Medical Officer for Cue
Health. “Integrating an all-new pharmacy experience within our
diagnostic-enabled care platform is yet another example of how Cue
is working to empower people to live their healthiest lives.”
Individuals can now utilize Cue to purchase over-the-counter
medications either a la carte or by subscription, which they can
manage by selecting their desired cadence. Customers can also
choose to consult with a clinician to get advice or learn more
about their condition and, if medically indicated, receive
prescription medication in a dosage that’s right for them.
For a full list of Cue’s pharmacy options and information about
the conditions that can be treated, please visit here.
About Cue Health
Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology
company that uses diagnostic-enabled care to empower people to live
their healthiest lives. The Cue Health platform offers individuals
and healthcare providers convenient and personalized access to
lab-quality diagnostic tests at home and at the point of care, as
well as on-demand telehealth consultations and treatment options
for a wide range of health and wellness needs. Cue’s customers
include federal and state public sector agencies and the private
sector, which includes healthcare providers, enterprises, and
individual consumers. Cue’s COVID-19 test was the first
FDA-authorized molecular diagnostic test for at-home and
over-the-counter use without a prescription. Cue has since received
Emergency Use Authorization from the FDA for its molecular mpox
test at the point of care and, to expand its test menu, the company
has a number of other submissions under review by the FDA. Cue,
founded in 2010, owns over 100 patents and is headquartered in San
Diego. For more information, please visit www.cuehealth.com.
Forward-Looking Statements
Statements in this press release about future expectations,
plans and prospects, as well as any other statements regarding
matters that are not historical facts, may constitute
“forward-looking statements”. The words, without limitation,
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“intend,” “may,” “plan,” “potential,” “predict,” “project,”
“should,” “target,” “will,” “would” and similar expressions are
intended to identify forward-looking statements, although not all
forward-looking statements contain these or similar identifying
words. Actual results may differ materially from those indicated by
such forward-looking statements as a result of various important
factors, including those related to the expected future diagnostic
test menu and the factors discussed in the “Risk Factors” section
of Cue’s Annual Report on Form 10-K for the year ended December 31,
2022 filed with the SEC on March 16, 2023. Any forward-looking
statements contained in this press release are based on the current
expectations of Cue’s management team and speak only as of the date
hereof, and Cue specifically disclaims any obligation to update any
forward-looking statement, whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230508005335/en/
press@cuehealth.com
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From May 2024 to Jun 2024
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jun 2023 to Jun 2024